Figure 4.
Distribution of AEs. The distribution of maximum grade of AEs by each patient on the azacitidine arm (A) and the control arm (B). The distribution of number of AEs by each patient on the azacitidine arm (C) and the control arm (D). The distribution of total toxicity burden by each patient on the azacitidine arm (E) and the control arm (F).